Amicus Therapeutics :
FOLD
FOLD
Stock Data
$14.49
$0.00 (0.00%)
Asset Type
N/A
Exchange
N/A
Currency
N/A
Country
N/A
Sector
N/A
Industry
N/A
Amicus Therapeutics Inc is a biotechnology firm dedicated to tackling rare diseases. It's known for Galafold, an innovative oral treatment for adults with Fabry disease, a genetic disorder. The company also works on developing therapies for other conditions, including through partnerships like those with the University of Pennsylvania and GlaxoSmithKline. Founded in 2002 and based in Princeton, New Jersey, Amicus Therapeutics strives to bring precision medicine to those facing life-altering diagnoses.
All Amicus Therapeutics Articles
15 Articles